Natixis Advisors LLC Grows Position in Option Care Health, Inc. (NASDAQ:OPCH)

Natixis Advisors LLC boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 9.3% during the third quarter, HoldingsChannel.com reports. The firm owned 88,751 shares of the company’s stock after acquiring an additional 7,529 shares during the period. Natixis Advisors LLC’s holdings in Option Care Health were worth $2,778,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in OPCH. Thrivent Financial for Lutherans lifted its holdings in shares of Option Care Health by 9.1% during the 2nd quarter. Thrivent Financial for Lutherans now owns 5,459,119 shares of the company’s stock valued at $151,218,000 after acquiring an additional 455,310 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Option Care Health by 6.5% in the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock worth $99,870,000 after buying an additional 218,844 shares during the period. Magnetar Financial LLC grew its stake in shares of Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after buying an additional 1,377,929 shares in the last quarter. Massachusetts Financial Services Co. MA acquired a new stake in shares of Option Care Health in the second quarter valued at about $68,003,000. Finally, Duquesne Family Office LLC lifted its position in Option Care Health by 172.8% during the 2nd quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock worth $51,849,000 after acquiring an additional 1,185,613 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Price Performance

Shares of OPCH opened at $23.13 on Monday. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market cap of $3.94 billion, a price-to-earnings ratio of 19.44, a PEG ratio of 2.33 and a beta of 1.32. The stock has a 50 day moving average of $27.62 and a 200-day moving average of $29.09.

Analysts Set New Price Targets

OPCH has been the subject of a number of recent analyst reports. Barrington Research lowered their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. JMP Securities upped their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Finally, Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.